255 related articles for article (PubMed ID: 12019102)
1. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
[TBL] [Abstract][Full Text] [Related]
2. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
[TBL] [Abstract][Full Text] [Related]
3. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
Hull CM; Brunton S
Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
[TBL] [Abstract][Full Text] [Related]
4. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
Nguyen HP; Stiegel KR; Downing C; Stiegel KR
Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
[TBL] [Abstract][Full Text] [Related]
5. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic review.
Rosa MI; Souza SL; Farias BF; Pires PD; Dondossola ER; dos Reis ME
An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1415-20. PubMed ID: 26247156
[TBL] [Abstract][Full Text] [Related]
7. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.
Spruance SL; Nett R; Marbury T; Wolff R; Johnson J; Spaulding T
Antimicrob Agents Chemother; 2002 Jul; 46(7):2238-43. PubMed ID: 12069980
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
Strand A; Böttiger D; Gever LN; Wheeler W
Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
10. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis.
Bernstein DI; Schleupner CJ; Evans TG; Blumberg DA; Bryson Y; Grafford K; Broberg P; Martin-Munley S; Spruance SL
Antimicrob Agents Chemother; 1997 Sep; 41(9):1961-4. PubMed ID: 9303394
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
[TBL] [Abstract][Full Text] [Related]
12. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
[TBL] [Abstract][Full Text] [Related]
13. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Morrel EM; Spruance SL; Goldberg DI;
Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
[TBL] [Abstract][Full Text] [Related]
14. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid.
Prescrire Int; 2011 Sep; 20(119):205-7. PubMed ID: 21954513
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir in the management of herpes labialis.
Yeo JM; Fiddian AP
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():95-103. PubMed ID: 6355056
[TBL] [Abstract][Full Text] [Related]
16. Failure of acyclovir cream in treatment of recurrent herpes labialis.
Shaw M; King M; Best JM; Banatvala JE; Gibson JR; Klaber MR
Br Med J (Clin Res Ed); 1985 Jul; 291(6487):7-9. PubMed ID: 3926067
[TBL] [Abstract][Full Text] [Related]
17. The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir.
Spruance SL; Freeman DJ; Stewart JC; McKeough MB; Wenerstrom LG; Krueger GG; Piepkorn MW; Stroop WG; Rowe NH
J Infect Dis; 1991 Apr; 163(4):728-34. PubMed ID: 1849159
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis.
Kaminester LH; Pariser RJ; Pariser DM; Weiss JS; Shavin JS; Landsman L; Haines HG; Osborne DW
J Am Acad Dermatol; 1999 Dec; 41(6):996-1001. PubMed ID: 10570387
[TBL] [Abstract][Full Text] [Related]
19. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting.
Semprini A; Singer J; Shortt N; Braithwaite I; Beasley R;
BMJ Open; 2017 Aug; 7(8):e017766. PubMed ID: 28775197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]